FDA Inspection
Larry BlankenshipLarry Blankenship – FDA Inspection, Aug 18, 2010
Record Details
This FDA Inspection record concerns Larry Blankenship, with an inspection on August 18, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Larry Blankenship
- Inspection Date
- August 18, 2010
- Product Type
- Drugs
View Company Profile
ID · fdf5825b-6755-41cd-b3a3-8299aa0f30c4
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 677926
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
8- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.60Informed consent
- 21 CFR 312.66Unanticipated problems
- 21 CFR 312.62(a)Accountability records
- 21 CFR 312.66Changes in research
- 21 CFR 50.55(f)Documentation of permission by parents or guardian
- 21 CFR 50.20Circumstances of obtaining consent
- 21 CFR 50.25(a)(5)Confidentiality, FDA inspection of records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Larry Blankenship
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 15, 2012 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Larry Blankenship
- FDA Inspection 783554 - 2012-05-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.